Cancer Research UK logo.
SearchDonate
  • Search

A study of tamoxifen, anastrozole and goserelin for women who have the BRCA 1 gene mutation (CIBRAC)

Overview

Cancer types:

Breast cancer

Status:

Results

Phase:

Other

Details

This study was for women who were at risk of developing breast cancer because they have the (mutation).

This study was open to women going to Family History clinics, BRCA clinics and the Higher Risk Breast Screening Programme in Northern Ireland.

Recruitment start: 14 March 2017

Recruitment end: 10 July 2020

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Mr Stuart McIntosh

Supported by

Cancer Research UK

Belfast Health & Social Care Trust

Experimental Cancer Medicine Centre (ECMC)

Queen's University Belfast

Northern Ireland Cancer Trials Network (NICTN)

Last reviewed: 05 Apr 2023

CRUK internal database number: 13880

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.